The first antitrust lawsuit brought since Donald Trump took office, along with his nominees for U.S. antitrust agencies, suggests that his administration, with its populist bent, will not lead to the wholesale antitrust relief that some businesses eager for deal movement were expecting. While moving away from the novel legal strategies that were pursued under Biden and back towards more traditional and predictable theories of harm, Trump and his Department of Justice Antitrust Division and Federal Trade Commission are still expected to scrutinize the concentration of power in "Big Tech," protect "Little Tech," and review healthcare-related deals, although private equity, transportation and infrastructure companies may see some lessening of scrutiny....
